Coya Therapeutics, Inc. (COYA) has 5 open-market insider trades by 4 insiders since 2023. The most active filer is Arun Swaminathan, CEO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Arun Swaminathan | CEO | — | 2 | $74K | 2024-11-13 |
| Fred Grossman | Chief Medical Officer | — | 1 | $20K | 2024-11-11 |
| David S. Snyder | CFO | — | 1 | $13K | 2024-11-14 |
| Ann Lee | Dir | — | 1 | $4K | 2023-08-22 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| David S. Snyder | CFO | Buy | $13K | 2024-11-14 |
| Arun Swaminathan | CEO | Buy | $37K | 2024-11-13 |
| Fred Grossman | Chief Medical Officer | Buy | $20K | 2024-11-11 |
| Arun Swaminathan | CEO | Buy | $37K | 2024-11-11 |
| Ann Lee | Director | Buy | $4K | 2023-08-22 |
Companies that share insiders with COYA, and sector peers with recent insider buying. Related by who files, not by how the stocks move.